MoneyWorks4Me

Bafna Pharmaceuticals informs about disclosure

01 Apr 2025 Evaluate
Bafna Pharmaceuticals has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SRJR Lifesciences LLP.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..